Rheumatoid Arthritis
4 years ago
Poll results are in! 48% of those that responded are not yet convinced of the benefits of omega-3 fish oil supplements in pts w/ RA! #ACR20 @RheumNow https://t.co/B6f8ecWj07
4 years ago
A large observat study showed no difference in risk of major CV events in RA pts that were newly started on either MTX or HCQ. A greater stroke risk but lower risk of MI & hospitalized HF was seen in MTX initiators. #Abst1993 #ACR20 @RheumNow
4 years ago
Dr Kaellmark reports on immunogenicity of adjuvant herpes zoster subunit vaccine in RA patients treated with JAKi. 40 RA patients and 20 controls. Satisfactory serological responses and tolerability seen. @rheumnow #ACR20 Abstr#1997 https://t.co/UlDe4NllU0
4 years ago
Abatacept in RA and ILD Patients: Dr Richard Conway (@RichardPAConway) #ACR20
https://t.co/e31VsnXFq5 https://t.co/sCrqLtXFFc
Hepatitis B, RA and Drug Risk with Drs. Stanley Cohen and Jack Cush
Dr. Cush interviews past ACR president and long-time friend Dr. Stan Cohen on treatment for liver disease in RA patients and new guidelines being released this morning at ACR 2020.
4 years ago
IA steroids for knee OA did NOT ^ X-ray progression to TKR vs IA Hyaluronic acid! Data from 2 cohorts, n=792 knees. Similar X-rays for single & multiple injections of either Rx. Not Randomized but helpful! Abstr#1652 @RheumNow #ACR20 @CRASCRRheum https://t.co/1yzr5QkIzV
4 years ago
New PT-CDAI showed agreement w/ MD(DO)-CDAI at id-ing active vs. controlled RA. Results suggest that PT-based swollen joints were more c/w physician assessments than PT tender joint counts. Useful for telemed! #ACR20 @RheumNow @Janetbirdope #ABS0483 https://t.co/tozp9qBRXT
4 years ago
Dr Castillo-Bustamante presents a human otopathological study demonstrating RA involvement of ossicular joints of middle ear. Is there a functional effect on hearing? @rheumnow @bososhea #ACR20 Abstr#1759 https://t.co/iWlKs2KdOW
4 years ago
Dr Winthrop reports on rates of influenza in RA in tofactinib clinical programme over 14-15 seasons. No significant differences in rates between tofa, ADA, MTX, and placebo. @rheumnow #ACR20 Abstr#L04 https://t.co/8RrG0I2Zwm